Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,3-Butanediol SCHEMBL11215123 | 0.88 | TDP1 (0.67) | TDP1TSHRTHRBALDH1A1ALOX15 | |
| 1,3-Butanediol SCHEMBL2382049 | 0.88 | TDP1 (0.67) | TDP1TSHRTHRBALDH1A1ALOX15 | |
| SCHEMBL25217822 | 0.88 | TDP1 (0.56) | TDP1TSHRTHRBALDH1A1TRPA1 | |
| 1,3-Butanediol SCHEMBL227565 | 0.87 | — | — | |
| 1,3-Butanediol SCHEMBL3427715 | 0.87 | TDP1 (0.53) | TDP1TSHRTHRBALDH1A1ALOX15 | |
| 1,3-Butanediol SCHEMBL222874 | 0.87 | — | — | |
| 1,3-Butanediol SCHEMBL8176 | 0.87 | — | — | |
| 1,3-Butanediol SCHEMBL9420276 | 0.86 | TSHR (0.41) | TDP1TSHRTHRBLMNA | |
| 1,3-Butanediol SCHEMBL7210975 | 0.84 | TDP1 (0.50) | TDP1TSHRTHRBALDH1A1ALOX15 | |
| 1,3-Butanediol SCHEMBL2587858 | 0.84 | TDP1 (0.50) | TDP1TSHRTHRBALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106832184-A | A kind of thermoplastic silicone polyurethane elastomer and preparation method thereof | 美瑞新材料股份有限公司 | 2017-06-13 | — | — | CN | claimed |
| EP-3600873-B1 | COMPOSITE ELEMENT | BASF SE (DE) | 2021-03-03 | — | — | EP | disclosed |
| EP-3600873-A1 | COMPOSITE ELEMENT | BASF SE (DE) | 2020-02-05 | — | — | EP | disclosed |
| EP-1954773-B1 | COATING COMPOSITION CONTAINING A LOW VOC-PRODUCING SILANE | MOMENTIVE PERFORMANCE MAT INC (US) | 2019-06-19 | — | — | EP | disclosed |
| EP-1987077-B1 | RADIATION CURABLE COMPOSITIONS | ALLNEX Belgium SA (BE) | 2017-04-12 | — | — | EP | disclosed |
| US-8367157-B2 | Radiation curable compositions | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2013-02-05 | — | — | US | disclosed |
| US-8063170-B2 | Radiation curable compositions | CYTEC SURFACE SPECIALITIES, S.A. (BE) | 2011-11-22 | — | — | US | disclosed |
| US-20110123768-A1 | PLASTIC FILM, METHOD FOR PRODUCING SAME, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-1991590-B1 | RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES SA (BE) | 2009-10-21 | — | — | EP | disclosed |
| US-20090004483-A1 | Radiation Curable Compositions | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2009-01-01 | — | — | US | disclosed |
| US-20090004377-A1 | Radiation Curable Compositions | ALLNEX BELGIUM S.A. (BE) | 2009-01-01 | — | — | US | disclosed |
| EP-1991590-A1 | RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2008-11-19 | — | — | EP | disclosed |
| EP-1987077-A1 | RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007099016-A1 | RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2007-09-07 | — | — | WO | disclosed |
| EP-1826224-A1 | Radiation curable compositions | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2007-08-29 | — | — | EP | disclosed |
| WO-2007093512-A1 | RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2007-08-23 | — | — | WO | disclosed |
| EP-1818349-A1 | Radiation curable compositions | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2007-08-15 | — | — | EP | disclosed |
| US-20020120028-A1 | Polyurethane elastomers which exhibit improved stability to hydrolysis | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123768-A1 | PLASTIC FILM, METHOD FOR PRODUCING SAME, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | SORT1, FAM162A, LCP1 | TDP1 2587/4885TSHR 2817/4885THRB 3998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.